Hey, we noticed you're in Canada but are currently viewing our US site. Would you like us to take you to the Canadian site, or do you want to stay on the US site?
Picking up what we're putting down? We thought you might be. Sign up for our free 4x-weekly newsletter to get "the gist" of what's going on in the sports world in less than 5 minutes.
Skip to Content

Olympics: ROC 15-year-old sensation fails drug test

Figure Skating

The GIST: In a stunning update to yesterday’s news about an ROC figure skater failing a drug test, the skater is allegedly 15-year-old sensation Kamila Valieva. Just awful.

February 10, 2022
AJENGLISH/TWITTER
AJENGLISH/TWITTER

The GIST: In a stunning update to yesterday’s news about an ROC figure skater failing a drug test, the skater is allegedly 15-year-old sensation Kamila Valieva. Just awful.

The latest: Valieva — who just made history as the first woman to land a quadruple jump at the Olympics — reportedly tested positive for a banned heart medication that can help endurance and increase blood flow. Previous Olympians who tested positive for this drug received months-long bans.

The context: It’s not exactly a shock to learn that a member of the ROC is at the center of this scandal. Russian athletes are competing as the ROC (Russian Olympic Committee) after the country was banned from the Games for a state-sponsored doping scheme during the 2014 Sochi Olympics.

  • What is shocking and deeply troubling is a 15-year-old being caught up in this mess. With countless examples of young athletes being abused by corrupt systems, our hearts break for Valieva.

What’s next: The International Olympic Committee has remained silent amid the reports, with the Russian Figure Skating Federation saying, “She is not suspended,” a statement further confirmed by Valieva’s appearance at yesterday’s training session.

  • That’s right, while we wait for a ruling on the ROC’s team-event gold, the teen star is still set to compete (and a favorite to win gold) in next week’s women’s singles competition. This story’s not going anywhere.